Salvatore Brugaletta
Editor-in-Chief at PCR Online
🇮🇹Interventional Cardiologist at @HospitalClinic & @Barnaclinic, Associate professor @UniBarcelona, Editor-in-chief @pcronline, #SoMe Editor @eurointerventio
Articles
-
Mar 8, 2025 |
pcronline.com | Giovanni Occhipinti |Salvatore Brugaletta
Selected in JACC: Cardiovascular Interventions by G. Occhipinti , S. Brugaletta At two-year follow-up, the use of sirolimus-eluting cobalt-chromium DynamX Drug Eluting Coronary Bioadaptor System (Elixir Medical Corporation) resulted in fewer target lesion failure (TLF) compared with the Resolute Onyx contemporary drug-eluting stent. References Authors Shigeru Saito, Johan Bennett, Holger M.
-
Jan 24, 2025 |
mdpi.com | Francisco Rafael Jimenez-Trinidad |Manel Sabaté |Salvatore Brugaletta |Sergi Calvo-Gomez
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
Jan 16, 2025 |
heart.bmj.com | Giovanni Occhipinti |Salvatore Brugaletta |Universitat de Barcelona
Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
-
Aug 21, 2024 |
pcronline.com | Giovanni Occhipinti |Salvatore Brugaletta
Selected in CirculationbyG. Occhipinti, S. BrugalettaThe rationale for this study was to provide direct evidence of colchicine's effects on plaque stabilization, particularly by assessing changes in plaque characteristics using optical coherence tomography (OCT).
Optimal minimal stent area and impact of stent underexpansion in left main up-front 2-stent strategy
Jul 9, 2024 |
pcronline.com | Salvatore Brugaletta
Selected in Circulation: Cardiovascular InterventionsbyS. BrugalettaThe present study aimed to revise the IVUS-derived segmental MSA criteria for optimal stent expansion in patients undergoing an up-front 2-stent strategy using the crush technique for LM bifurcation lesions to predict the 5-year clinical outcomes.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 13K
- Tweets
- 11K
- DMs Open
- Yes
RT @mirvatalasnag: @EuroInterventio @G_Tarantini01 @sbrugaletta are now live Link to the paper being discussed 👉 https://t.co/6VvQwGvYtF
RT @DFCapodanno: I am pleased to announce that the new Impact Factor of EuroIntervention is the highest in its 20-year history: 9.5. Ranked…
RT @EuroInterventio: #EIJonAir - High-risk PCI in surgically ineligible patients https://t.co/9cPcKT4QE8
